Sandbox:Zahir: Difference between revisions
Line 152: | Line 152: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* hypoproteinemia | |||
* hypoalbuminemia | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- |
Revision as of 15:09, 23 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Differentiating [Disease name] from other Diseases
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Diagnosis | Gold standard | Additional findings | Others | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||
Abdominal pain | Bowel habits | Blood in stool | Weight loss | General appearance | Abdominal exam | Rectal exam | Genitourinary exam | CBC | Tumor markers | Stool test | Colonoscopy | Barium enema | Ultrasound | CT scan | ||||
Rectal carcinoma[1][2][3][4][5] | LLQ | Constipation/diarrhea | + | + |
|
|
|
NL | Anmeia |
|
FOBT + | mass/polyp | Apple core apearance | endoscopic/trnasrectal US detects tumor extent | determine tumor stage | colonoscopy with biopsy | DRE & proctoscopy detects tumor localization & extension |
|
Rectal polyp | + | mucous diarrhea | + | + | NL | NL |
|
|||||||||||
Anal cancer | ||||||||||||||||||
Hemorrhoids | ||||||||||||||||||
Rectal intususception | ||||||||||||||||||
Foreign body | ||||||||||||||||||
Diseases | Abdominal pain | Bowel habits | Blood in stool | Weight loss | General appearance | Abdominal exam | Rectal exam | Genitourinary exam | CBC | Tumor markers | Stool test | Colonoscopy | Barium enema | Ultrasound | CT scan | Others | Gold standard | Additional findings |
Prostate cancer | ||||||||||||||||||
Fecal impaction | ||||||||||||||||||
Anal stenosis | ||||||||||||||||||
Hypertrophied anal papillae | ||||||||||||||||||
Endometriosis | ||||||||||||||||||
Uterine malignancy | ||||||||||||||||||
Diseases | Abdominal pain | Bowel habits | Blood in stool | Weight loss | General appearance | Abdominal exam | Rectal exam | Genitourinary exam | CBC | Tumor markers | Stool test | Colonoscopy | Barium enema | Ultrasound | CT scan | Others | Gold standard | Additional findings |
Cervical malignancy | ||||||||||||||||||
Metastases | ||||||||||||||||||
Pelvic abscess | ||||||||||||||||||
Pelvic sarcoma | ||||||||||||||||||
Parasacral neurogenic tumor |
References
- ↑ Chiara Molinari, Federica Matteucci, Paola Caroli & Alessandro Passardi (2015). "Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer". Clinical colorectal cancer. 14 (4): 227–238. doi:10.1016/j.clcc.2015.05.014. PMID 26170142. Unknown parameter
|month=
ignored (help) - ↑ William Hamilton & Deborah Sharp (2004). "Diagnosis of colorectal cancer in primary care: the evidence base for guidelines". Family practice. 21 (1): 99–106. PMID 14760054. Unknown parameter
|month=
ignored (help) - ↑ Wolfgang B. Gaertner, Mary R. Kwaan, Robert D. Madoff & Genevieve B. Melton (2015). "Rectal cancer: An evidence-based update for primary care providers". World journal of gastroenterology. 21 (25): 7659–7671. doi:10.3748/wjg.v21.i25.7659. PMID 26167068. Unknown parameter
|month=
ignored (help) - ↑ V. Raman Muthusamy & Kenneth J. Chang (2007). "Optimal methods for staging rectal cancer". Clinical cancer research : an official journal of the American Association for Cancer Research. 13 (22 Pt 2): 6877s–6884s. doi:10.1158/1078-0432.CCR-07-1137. PMID 18006793. Unknown parameter
|month=
ignored (help) - ↑ Mohammad Sadegh Fazeli & Mohammad Reza Keramati (2015). "Rectal cancer: a review". Medical journal of the Islamic Republic of Iran. 29: 171. PMID 26034724.